nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Pregnancy/Postpartum"

 

Lithium Use During Pregnancy and Maternal and Infant Outcomes
July 13, 2018   

Lithium is a staple and highly effective medication for the treatment of bipolar disorder; however, past data have indicated somewhat mixed data regarding the teratogenic effects of lithium use during pregnancy...
 Continue reading
Placental Biology and Genetic Risk for Schizophrenia
June 18, 2018   

In a recent study, the relationship between placenta biology and genetic risk for schizophrenia in the presence of early-life complications (ELCs) was examined...
 Continue reading (Members only)
Mama Bare: Depression During Pregnancy and the Postpartum Period
May 16, 2018   

Pregnancy and the birth of a child are often viewed as joyous, miraculous events. However, a significant portion of women suffer with depression during pregnancy and in the postpartum period...
 Continue reading
Risk of Congenital Malformations With Stimulant Use During Pregnancy
February 16, 2018   

In a recent cohort study from the International Pregnancy Safety Consortium the relationship between intrauterine exposure to stimulants, such as methylphenidate and amphetamine and risk of...
 Continue reading
Review: Benefits vs. Risks of Aripiprazole During Pregnancy
February 7, 2018   

A systematic literature search and review evaluated the available data on the use of aripiprazole during pregnancy, peripartum and lactation...
 Continue reading
Do Anxiety Disorders During Pregnancy Increase Risk of Adverse Birth Outcomes?
October 13, 2017   

The decision to treat mental health conditions, such as anxiety disorders, during pregnancy is an important and personal one; the health of the mother must be carefully weighed against potential adverse outcomes to the fetus. A recently published study adds valuable data on which such decisions can be informed....
 Continue reading
Perinatal Antidepressant Use and Psychiatric Disorders in Offspring
September 29, 2017   

A recent Danish cohort study examined the association between in utero exposure to antidepressants and risk of psychiatric disorders...
 Continue reading
Maternal and Postpartum Depression: Risk Factors, Mortality, and Child Outcomes
May 31, 2017   

Depression during the postpartum period is not uncommon, with prevalence rates as high as 20% (and perhaps even more prevalent in low-income countries). Recent years have called for increased recognition of postpartum depression, reduction of associated stigma, and support for new mothers in need of treatment...
 Continue reading
Antidepressants and Risk for Autism, ADHD
May 12, 2017   

Recently published studies suggests that mothers' use of antidepressants during early pregnancy does not increase the risk of their children developing autism or attention deficit hyperactivity disorder, conditions previously associated with these medications....
 Continue reading
Marijuana Use in Pregnant Women Has Increased
January 13, 2017   

In a recent observational study, the prevalence of marijuana use in pregnant versus nonpregnant women was examined...
 Continue reading
123
Top of Page